-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, O3c8UeyUWa4qCZOfEarJGo5hllbPF/EAvCcGNVtsis5C8urvYlCwWVTvNn3WpTBw r2oYVryn/mj5novovMEAGA== 0000950005-03-001050.txt : 20031107 0000950005-03-001050.hdr.sgml : 20031107 20031107155016 ACCESSION NUMBER: 0000950005-03-001050 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20031106 ITEM INFORMATION: Other events ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 20031107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CELLEGY PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000887247 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820429727 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-26372 FILM NUMBER: 03985210 BUSINESS ADDRESS: STREET 1: 349 OYSTER POINT BLVD. STREET 2: SUITE 200 CITY: SO. SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6506262200 MAIL ADDRESS: STREET 1: 349 OYSTER POINT BLVD. STREET 2: SUITE 200 CITY: SO. SAN FRANCISCO STATE: CA ZIP: 94080 8-K 1 p17847_8-k.txt CURRENT REPORT SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2003 CELLEGY PHARMACEUTICALS, INC. - -------------------------------------------------------------------------------- (Exact name of Registrant as specified in its charter) California ------------------------------------------------------ (State or other jurisdiction of incorporation) 0-26372 82-0429727 - ---------------------------- ------------------------ (Commission (IRS Employer File Number) Identification No.) 349 Oyster Point Boulevard, Suite 200 South San Francisco, CA 94080 - ------------------------------------------------------------- ------------------ (Address of principal executive offices) (Zip Code) (650) 616-2200 - -------------------------------------------------------------------------------- (Registrant's telephone number, including area code) - -------------------------------------------------------------------------------- (Former name or former address, if changed since last report) ITEM 5: OTHER EVENTS. On November 6, 2003, Cellegy Pharmaceuticals, Inc. (the "Company") issued a press release announcing that it has appointed Mr. Richard C. Williams to the position of Chairman of its Board of Directors, assuming that responsibility from K. Michael Forrest who will retain his positions of President and CEO and will remain a member of the Board of Directors. The Company also appointed Mr. John Q. Adams, Sr. and Mr. Thomas M. Steinberg to its Board as Directors. At the same time, Cellegy accepted the resignations of three of its directors, Mr. Jack Bowman, Mr. Alan Steigrod and Mr. Larry Wells. ITEM 7: FINANCIAL STATEMENTS AND EXHIBITS. (c) Exhibits. None. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 7, 2003 CELLEGY PHARMACEUTICALS, INC. By: /s/ Richard Juelis ------------------ A. Richard Juelis Vice President, Finance and Chief Financial Officer -----END PRIVACY-ENHANCED MESSAGE-----